Akèy › Metiyè › Regulatory Affairs Managers › Cambridge, MA
Regulatory Affairs Managers nan Cambridge, MA: Salè H-1B
99 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Cambridge, MA. Salè baz medyàn ofri $169,288; mwatye mitan $146,928–$196,379.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $130,000 |
| Nivo II (kalifye) | $155,000 |
| Nivo III (eksperyans) | $183,950 |
| Nivo IV (plen kompetans) | $213,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Takeda Development Center Americas, Inc. | 32 | $185,065 |
| Sanofi US Services Inc. | 13 | $133,026 |
| Blueprint Medicines Corporation | 6 | $152,286 |
| Beam Therapeutics, Inc. | 5 | $200,000 |
| Intellia Therapeutics | 4 | $176,450 |
| Sage Therapeutics, Inc. | 4 | $160,416 |
| Genzyme Corporation | 4 | $132,782 |
| BioNTech US Inc. | 3 | $188,000 |
| Sarepta Therapeutics, Inc. | 3 | $190,000 |
| Alnylam US, Inc. | 3 | $140,000 |
| Syros Pharmaceuticals, Inc. | 3 | $316,323 |
| UKA North America LLC | 2 | $155,000 |
| ModernaTX, Inc. | 2 | $216,100 |
| Biogen Inc. | 1 | $120,078 |
| nference, inc. | 1 | $160,000 |
| Evelo Biosciences, Inc. | 1 | $209,000 |
| Omega Therapeutics, Inc. | 1 | $215,000 |
| Moderna Services, Inc. | 1 | $180,294 |
| Boston Pharmaceuticals | 1 | $188,780 |
| Novartis Pharmaceuticals Corporation | 1 | $150,176 |
| BlueRock Therapeutics LP | 1 | $145,000 |
| InterSystems Corporation | 1 | $157,247 |
| BeiGene USA, Inc. | 1 | $175,000 |
| Concert HealthAI ManagementCo, LLC | 1 | $195,458 |
| Kadmon Corporation, LLC | 1 | $120,000 |
| Ipsen Biopharmaceuticals, Inc. | 1 | $210,891 |
| Regeneron Pharmaceuticals, Inc. | 1 | $220,000 |
| QuantCo, Inc. | 1 | $135,000 |
Tit travay
- Director, Global Regulatory Affairs4
- Senior Manager, Pharmacovigilance Operations3
- Senior Manager, Regulatory Affairs3
- Regulatory Strategist3
- Senior Manager, Global Regulatory Affairs, Marketed Products3
- GRA Device Lead Specialty Care Device & Combination Products3
- Associate Director2
- Associate Director, Regulatory Affairs2
- Associate Director, Regulatory Strategy2
- Manager, PV Validation2
- Director, Regulatory Affairs2
- Associate Director, CMC Program Lead, Cell Therapies2
- Project Developer2
- Safety Governance Expert2
- SVP Global Regulatory Affairs & Quality & Op Excellence2
Pwonse H-1B nan Cambridge, MA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).